Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 20, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/13/17 - "Compositions and Methods for Immunizing against C. Difficile" in Patent Application Approval Process (USPTO 20170304423)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors Pietrobon, Patricia; Foglia, Ginamarie; De Bruyn, Guy; Gurunathan, Sanjay, filed on July 10, 2017, was made available online on November 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent ap
11/13/17 - "Immediate Release Abuse Deterrent Tablet" in Patent Application Approval Process (USPTO 20170304297)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Sareen, Rahul; Fesharaki, Shahin; Shah, Parag, filed on July 3, 2017, was made available online on November 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Alle
11/13/17 - "Immunoglobulin Aggregate Removal" in Patent Application Approval Process (USPTO 20170305964)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Hepbildikler, Stefan; Kuhne, Wolfgang; Rosenberg, Eva; Winter, Gerhard, filed on April 13, 2017, was made available online on November 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appl
11/13/17 - "New Indication of Cinacalcet Hcl Pharmaceutical Composition for Treating Cancer" in Patent Application Approval Process (USPTO 20170304228)
By a News Reporter-Staff News Editor at Cancer Gene Therapy Week A patent application by the inventors Chen, Chiu-Hung; Chuang, Show-Mei; Way, Tzong-Der; Hsiao, Nai-Wan, filed on October 23, 2015, was made available online on November 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent app
11/13/17 - "New Indication of Monobenzone Pharmaceutical Composition for Treating Cancer" in Patent Application Approval Process (USPTO 20170304218)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors Chen, Chiu-Hung; Chuang, Show-Mei; Way, Tzong-Der; Hsiao, Nai-Wan, filed on October 23, 2015, was made available online on November 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent applica
11/13/17 - "Orally Disintegrating Solid Pharmaceutical Dosage Unit Containing a Partus Control Substance" in Patent Application Approval Process (USPTO...
"Orally Disintegrating Solid Pharmaceutical Dosage Unit Containing a Partus Control Substance" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors PLATTEEUW, Johannes Jan; COELINGH BENNINK, Herman Jan Tijmen, filed on September 29, 2015, was made available onli
11/13/17 - "While Mr. Azar has experience within HHS, his ties to the pharmaceutical industry must be fully reviewed during the confirmation process."
WASHINGTON- U.S. Representative Evan Jenkins issued the following statement today on the nomination of Alex Azar as the new secretary of Health and Human Services:. While Mr. Azar has experience within HHS, his ties to the pharmaceutical industry must be fully reviewed during the confirmation process. West Virginians must know that Mr. Azar is full
11/13/17 - 'Yes on Issue 2' Campaign: Get the Truth About the Anti-Issue 2 Coalition
For example, Mended Hearts, Inc., a patient advocacy network, has received $970,000 from drug company giant AstraZeneca; the National Association of Mental Illness of Ohio, another patient advocacy group, has received $185,000 over the past decade from AstraZeneca; the American Congress of Obstetricians and Gynecologists received $65,000 from Abbvi
11/13/17 - Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems
By a News Reporter-Staff News Editor at Pharma Business Week Abbott has secured U.S. Food and Drug Administration 510 clearance for its Alinity? ci-series instruments for clinical chemistry and immunoassay diagnostics. "Healthcare systems across the United States are under pressure to deliver better care for patients," said Brian Blaser, execu
11/13/17 - ACADIA Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017
By a News Reporter-Staff News Editor at Clinical Trials Week ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, announced that it will report its financial results for the third quarter ended Septemb
11/13/17 - Acorda Provides Financial and Pipeline Update for Third Quarter 2017
By a News Reporter-Staff News Editor at Pharma Business Week Acorda Therapeutics, Inc. provided a financial and pipeline update for the third quarter ended September 30, 2017. Research and development expenses for the quarter ended September 30, 2017 were $33.3 million, including $2.0 million of share-based compensation and$. 03 million of restru
11/13/17 - Acorda Therapeutics Inc. Files SEC Form 8-K, Current Report: (Oct. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acorda Therapeutics Inc. was posted on October 31, 2017. The SEC file number is 0001564590-17-020447.. A U.S. Securities and Exchange Commission fili
11/13/17 - Actor Chuck Norris and Wife Gena Norris Announce Multi-Million Dollar Lawsuit against Pharmaceutical Companies for Dangerous MRI Drug
By a News Reporter-Staff News Editor at Pharma Business Week Chuck and Gena Norris announced that they have filed a lawsuit against eleven drug companies, including McKesson and Bracco, that they claim are responsible for the gadolinium contrast dye used during the MRIs that nearly cost Gena her life. The couple, represented by attorneys Brooks C
11/13/17 - Adamas Pharmaceuticals Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals: (Oct. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on October 27, 2017. The SEC file number is 0000899140-17-000641.. A U.S. Securities and Exchange Commission f
11/13/17 - Alexion Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Oct. 26, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on October 26, 2017. The SEC file number is 0000899866-17-000174.. A U.S. Securities and Exchange Commission
11/13/17 - Alexion Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Oct. 26, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on October 26, 2017. The SEC file number is 0000899866-17-000172.. A U.S. Securities and Exchange Commission
11/13/17 - Alexion to Present at the 26th Annual Credit Suisse Healthcare Conference
By a News Reporter-Staff News Editor at Pharma Business Week Alexion Pharmaceuticals, Inc. announced that management will present at the 26th Annual Credit Suisse Healthcare Conference in Scottsdale, AZ on Tuesday, November 7, 2017 at 10:20 a.m., Mountain Time. An audio webcast of the presentation will be available live. Keywords for this news ar
11/13/17 - Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual...
By a News Reporter-Staff News Editor at Clinical Trials Week Allergan plc presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and safety of ulipristal acetate, an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids. "For a condition that affe
11/13/17 - Allergan's Trademark Application for "REFRESH FUSION" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "REFRESH FUSION" by Susan J. Hinchey, representing Allergan. This application was made available to the public on October 30, 2017. The owner/registrar informa
11/13/17 - Allergan's Trademark Application for "REFRESH OPTIVE FUSION" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "REFRESH OPTIVE FUSION" by Susan J. Hinchey, representing Allergan. This application was made available to the public on October 30, 2017. The owner/registrar
11/13/17 - Amphastar Pharmaceuticals, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 26, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amphastar Pharmaceuticals, Inc. was posted on October 26, 2017. The SEC file number is 0001104659-17-064080.. A U.S. Securities and Exchange Commissi
11/13/17 - Ampio Pharmaceuticals, Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals: (Oct. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Ampio Pharmaceuticals, Inc. was posted on October 27, 2017. The SEC file number is 0001104659-17-064390.. A U.S. Securities and Exchange Commission f
11/13/17 - An Application for the Trademark "VALOREY" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "VALOREY" by Marilyn F. Kelly, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Marilyn F. Kelly, Bristol-Myers Squi
11/13/17 - Apexigen Announces Late-Breaking Oral Presentation for Immune Activating Antibody APX005M at the 2017 Society for Immunotherapy of Cancer SITC Annual...
By a News Reporter-Staff News Editor at Cancer Vaccine Week Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing antibody-based therapeutics for the treatment of cancer with an emphasis on new Immuno-Oncology agents, announced that an abstract for Company's lead I-O agent APX005M, a CD40 agonistic...
11/13/17 - Argos Therapeutics Inc. Files SEC Form 8-K, Current Report: (Oct. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Argos Therapeutics Inc. was posted on October 27, 2017. The SEC file number is 0001171843-17-006365.. A U.S. Securities and Exchange Commission filin
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415